Wolverine Blend: What It Is and What It Does

What Wolverine Blend is

Wolverine Blend pairs two of the most-studied repair peptides: BPC-157 and TB-500 (a fragment of thymosin beta-4). It is supplied as an analytical-grade reference material for laboratory research.

Where it comes from

Wolverine Blend is a research blend of two separately discovered repair peptides, BPC-157 and TB-500, rather than a single compound. BPC-157 — short for Body Protection Compound 157 — is a synthetic 15-amino-acid sequence identified in the 1990s from a protective protein in human gastric juice, and it proved unusually stable outside the body. TB-500 is a lab-made copy of the active region of thymosin beta-4, a natural protein the body uses for building and repair. The two are frequently paired in recovery research because they approach tissue repair from complementary directions.

What it does — in plain terms

This blend pairs two compounds that researchers study around tissue repair from different angles. BPC-157 is a fragment copied from a protective stomach protein, studied for tendon, muscle, and gut-lining repair; TB-500 is the active piece of thymosin beta-4, studied for wound healing, cell migration, and new blood-vessel growth. The point of a blend is to look at how they behave together rather than one at a time. For the primary studies behind each ingredient, open its own post.

How it works

This blend pairs two of the most-studied repair peptides, and the logic is that they reach overlapping goals by different routes. Neither works through a single shared receptor with the other; instead, BPC-157 is studied mainly around blood supply and repair signaling, while TB-500 is studied around the movement of repair cells. Pairing them is a common research design, but the combination itself has not been validated as a blend — the evidence is on each peptide on its own.

BPC-157 behaves in animal and cell studies like a repair dispatcher: it does not appear to force a new process so much as speed the healing the body already knows how to do, above all by promoting new blood-vessel growth (angiogenesis) through the VEGF pathway. Because injured tissue can only rebuild when it receives oxygen and nutrients, that vascular effect is the most consistent thread in its literature.

TB-500 comes at repair from the cell-movement side. As the active fragment of thymosin beta-4, it binds actin — a core building block of a cell's internal scaffolding — and is studied for helping repair cells migrate into damaged tissue, with new blood-vessel formation as a secondary theme. So the two overlap on angiogenesis but reach it differently: BPC-157 via the VEGF signal, TB-500 via cell migration and actin. The primary studies for each are in their own posts.

What the research shows

Unlike its two ingredients, this blend has not been studied as a combination — so the honest evidence base is the separate literature on BPC-157 and TB-500, most of which is preclinical (cell and animal work). The studies below are split evenly between the two: three concern the BPC-157 component and three concern thymosin beta-4, the parent protein of the TB-500 component. Each is about a single ingredient, not the blend.

• Pharmaceuticals, 2025 — reviewed published literature and patents on medical-research applications of the BPC-157 component.
• Cell and Tissue Research, 2019 — reviewed the BPC-157 component's effects on musculoskeletal soft-tissue healing, describing accelerated tendon, ligament, and muscle recovery in animal models.
• Frontiers in Pharmacology, 2021 — surveyed the BPC-157 component's role in wound-healing research across preclinical models.
• Annals of the New York Academy of Sciences, 2007 — gave an overview of the beta-thymosins, the protein family that includes thymosin beta-4 — the source of the TB-500 component.
• International Immunopharmacology, 2023 — reviewed thymosin beta-4 (the parent protein of the TB-500 component) in regenerative-research settings.
• Annals of the New York Academy of Sciences, 2010 — summarized animal studies of thymosin beta-4 (the TB-500 component) as a tissue-repair peptide.

What Wolverine Blend is studied for

Tendon, muscle, and soft-tissue repair — BPC-157. The most-studied use of the BPC-157 component: in animal models it speeds the healing of slow-mending tissues like tendon and muscle, which have a poor blood supply of their own.

Wound healing and cell migration — TB-500. The TB-500 component is examined for helping repair cells migrate into a wound, drawing on the actin-binding role of its parent protein thymosin beta-4.

New blood-vessel growth (angiogenesis) — both. Angiogenesis is the point where the two literatures meet: BPC-157 through the VEGF pathway and TB-500 as a secondary theme, which is much of the rationale for pairing them.

Recovery-research models — the blend. The pair is popular in recovery-focused research precisely because the two peptides are thought to cover repair from different angles, though the combination remains untested as a unit.

Storage & handling

As a lyophilized (freeze-dried) powder, this two-peptide reference material is most stable kept cold and dark — refrigerated, or frozen for longer holds. Once reconstituted with bacteriostatic water it should be refrigerated at roughly 2-8 °C, kept out of light, and protected from repeated freeze-thaw cycles, which are hard on peptide mixtures. Because it is a blend of two peptides, use it promptly once reconstituted. See the reconstitution reference below for the concentration math.

Reconstitution reference

Standard laboratory reconstitution volumes for Wolverine Blend, from the VNG Reconstitution Sheet. See the full reconstitution guide for the method and concentration math.